Release date: 2017-09-05

According to San Francisco-based startup Catalia Health, artificial intelligence-based robots can help chronically manage patients better in the absence of healthcare professionals.

As a health technology startup that has only been established for three years, Catalia Health has received $3.75 million in financing from Kosra Ventures, and has developed software for pairing with robots, Mabu, and through patients with chronic diseases. Cooperation to improve drug compliance, thereby improving patient symptom management and reducing the probability of hospitalization.

Cory Kidd, founder and CEO of Catalia Health, told ZDNet that the establishment and development of the company is in line with the climax of interactive research between humans and robots for nearly 20 years. Kidd said: "When we talk face to face with people in the real world, we will focus on dialogue, build stronger relationships, and trust each other, and the establishment of such communication and trust mechanisms may continue into the technology world. Say, when humans talk to robots, they can use the observation of the eyes to get the psychological effect of face-to-face communication."

Pharmaceutical companies and healthcare providers intend to offer free hardware and software services to Catalia Health's chronically ill patients. If the two companies cooperate, the pharmaceutical company will provide patient information for Catalia Health, and Catalia Health's technology will be directly integrated with the pharmacy system. The patient is thus included in the care management plan.

In the next few days, the patient will receive a parcel containing the “personalized medical partner” they need. Kidd said that once Mabu is started, it will introduce itself to the patient and confirm the identity of the patient, thus establishing a relationship with each other.

For how robots build relationships with patients, Kidd added: “Initially, Mabu had a simple conversation with the patient, such as 'I know what type of medication you need to take every day, and know when to take it usually', through a similar simple conversation. A partnership between Mabu and patients can be established."

In the case of Mabu's understanding of the patient's condition, the patient can ask Mabu to periodically remind him when to eat what type of medication. In addition to the conversation about the patient's condition, Mabu can also communicate daily with the patient. For example, Mabu will ask the patient how it feels? Based on the patient's answer, Mabu can extend more topics to communicate.

Kidd said that Mabu is somewhat similar to personal virtual assistants like Amazon's Alexa, Microsoft's Cortana and Apple's Siri, but Mabu's conversation is not open. “In many cases, the patient’s physical condition does not allow him to go to Mabu for various exchanges. Therefore, we deliberately designed it as a non-open dialogue. Our original intention is not to try to solve artificial intelligence, nor to develop An intelligent robot. What we focus on is a focused discussion of a specific disease, or to help patients with concentrated treatment," Kidd explained.

Currently, Catalia Health's products are designed to treat patients with rheumatoid arthritis, heart disease and kidney cancer. To ensure that Mabu can provide valuable help to each patient, Catalia Health is currently working on a treatment option for one of the chronic diseases. The key is how to make Mabu understand and adapt to each patient because Mabu is not a “one size fits all”. "The perfect solution."

Kidd said that we need to focus on how to help and guide patients correctly, such as what we need to check every day, every week, every month? What kind of advice do you need to give patients? Heart failure patients need to measure their body weight, blood pressure and strict follow-up of the low-salt diet every morning. This is obviously different from rheumatoid arthritis patients, who need to do the right amount of exercise every day and take only one drug a day.

According to the World Health Organization, the world faces a shortage of more than 7 million health care workers. According to statistics in 2003, in developed countries, the average level of long-term treatment for chronic diseases is only 50%.

The current status quo is that many patients do not continue to receive treatment after discharge and do not insist on taking drugs, so Kidd said that his company is working to explore the reasons behind it and provide patients with drug compliance. Kidd added that the data collected from Mabu's interaction with patients can be used to analyze a patient's condition and thus be more widely used in the medical industry. All data will be included in the system, and a summary analysis report will be provided to the patient at the end of the month to facilitate the next treatment.

In addition, Kidd said that Mabu is not intended to replace human medical professionals, but to improve the relationship between patients and professional caregivers, and to improve patient compliance.

Source: billion euro network

Industrial Applications Nitrile Gloves

Industrial Applications Nitrile Gloves,Industrial Nitrile Gloves,Food Grade Disposable Gloves,Food Grade Nitrile Gloves

Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshimedicals.com